Last reviewed · How we verify
Lac-Hydrin — Competitive Intelligence Brief
marketed
alpha-Hydroxy Acid [EPC]
Immunology
Small molecule
Live · refreshed every 30 min
Target snapshot
Lac-Hydrin (AMMONIUM LACTATE) — Sun Pharma.
Comparator set (2 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lac-Hydrin TARGET | AMMONIUM LACTATE | Sun Pharma | marketed | alpha-Hydroxy Acid [EPC] | 1985-01-01 | |
| Glycolic Acid 70% | Glycolic Acid 70% | Combined Military Hospital Abbottabad | marketed | Alpha-hydroxy acid (AHA) exfoliant | ||
| Lactic acid (Dermacid) | Lactic acid (Dermacid) | Sanofi | phase 3 | Alpha-hydroxy acid (AHA) / Keratolytic agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (alpha-Hydroxy Acid [EPC] class)
- Sun Pharma · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lac-Hydrin CI watch — RSS
- Lac-Hydrin CI watch — Atom
- Lac-Hydrin CI watch — JSON
- Lac-Hydrin alone — RSS
- Whole alpha-Hydroxy Acid [EPC] class — RSS
Cite this brief
Drug Landscape (2026). Lac-Hydrin — Competitive Intelligence Brief. https://druglandscape.com/ci/ammonium-lactate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab